“2014 Opportunities in the French Blood Banking Market” is a new strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies.

Rationale

During the next five years, the French blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology.

The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications.

Strategic Recommendations

• New product development opportunities with significant market appeal.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.

The report explores future marketing and technological trends in the France; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years.

Blood Typing and Grouping Tests

ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du).

Infectious Disease Screening Tests

AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT.

Sales and Market Share Analysis

Sales and market share estimates of leading suppliers of blood banking of reagents and instruments, by individual product.

Competitive Assessments

Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D.

Market Segmentation Analysis

Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth, and key suppliers.

Test volume and sales forecasts for over 40 blood banking tests, including NAT, by market segment:

• Blood Centers
• Hospitals
• Commercial/Private Laboratories

Current and Emerging Products

• Analysis of current and emerging blood banking tests.
• Review of automated and semi-automated analyzers, including their operating characteristics, features, and selling prices.

Technology Review

• Assessment of current and emerging technologies, and their potential applications for the blood banking market.
• Comprehensive lists of companies developing or marketing new technologies and products by test.

Table of Contents

I. Introduction

II. Major Product Development Opportunities
A. Blood Typing and Grouping
B. Infectious Disease Screening C. Auxiliary

III. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts

IV. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection

V. Worldwide Technology and Market Overview
A. Major Blood Typing, Grouping and Infectious Disease Screening Tests
1. Blood Typing and Grouping Tests
a. ABO
b. Antibody Panels
c. Antibody Screening
d. Antigen Typing
e. Antiglobulin Test
f. Crossmatch
g. HLA Typing
h. Rh
i. Other Blood Groups
2. Infectious Disease Screening Tests
a. AIDS
- Structure and Composition
- Classification
- Origin of AIDS
- Animal Lentivirus Systems
- Virus Receptors
- HIV Infections in Humans
Pathogenesis & Pathology
Overview of Course of HIV Infection
- CD4T Lymphocytes and Memory Cells
- Monocytes and Macrophages
- Lymphoid Organs
- Neural Cells
- Viral Coinfections
Clinical Findings
- Plasma Viral Load
- Pediactric AIDS
Neurologic Disease
Opportunistic Infections
Protozoa
Fungi
Bacteria
- Viruses
- Cancer
- Immunity
- Laboratory Diagnosis
Virus Isolation
Serology
Detection of Viral Nucleic Acid or Antigens
- Epidemiology
Worldwide Spread of AIDS
United States
Routes of Transmission
- Prevention, Treatment, And Control
Antiviral Drugs
Vaccines Against HIV
- Transmission of HIV in Blood Products
- HIV Transmission in Transplant and Artificial Insemination Recipients
- Diagnostic Tests
Enzyme Immunoassay Interpretation
Specificity, Sensitivity, and Predictive
Value of Enzyme Immunoassay
- Competition Assays
- Western Blot Technique
- Immuno-Fluorescence Assay (IFA)
- Radioimmunoprecipitation
- HIV-1/HIV-2 Combination Testing
- Methods of HIV-Antigen Detection
- Antigen Assays and Blood Screening
- Urine Tests
- DNA Probes
Overview
Quantitative Polymerase Chain Reaction
In Situ PCR
Needed Improvements
- Viral Load/Drug Resistance Testing
- Genotype and Phenotype Testing
- Blood Banking Considerations
b. Hepatitis
- Hepatitis A
- Hepatitis B
Structure and Composition
Replication of Hepatitis B Virus
- Hepatitis C
- Hepatitis D (Delta Hepatitis)
- Hepatitis E
- Hepatitis G
- Hepatitis Virus Infections In Humans
Pathology
- Clinical Findings
- Laboratory Features
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D
Hepatitis E
- Virus-Host Immune Reactions
- Epidemiology
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D (Delta Agent)
- Vaccines and Drugs
c. Cytomegalovirus
- Background
- Chorioretinitis
- Gastrointestinal
- Central Nervous System Disease
- Diagnostic Tests
- Vaccines and Drugs
d. Syphilis
- Background
- Diagnostic Tests
- Vaccines and Drugs
e. West Nile Virus
- Background
- Clinical Syndromes
- Diagnostic Tests
- Vaccines and Drugs
f. Parvovirus B19
- Microbiology
- Epidemiology
- Clinical Syndromes
Erythema Infectiosum Slapped (cheek)
Adult Polyarthropathy
Transient Aplastic Crisis
Transient Pancytopenia
Red Cell Aplasia in the Immunocompromised
Perinatal Infections
- Diagnosis
- Treatment
g. Creutzfeldt-Jakob's Disease
- Background
- Transmission
- Diagnostic Tests
- Major Commercial and Academic Players
Bayer
Disease Sciences/BioTec Global
Imperial College School of Medicine
Ortho-Clinical Diagnostics
Pall
ProMetic Life Sciences
Proteome Sciences/Idexx
Q-One Biotech
Serono
U.S. Agricultural Research Service
- Drugs
- Vaccines
h. Malaria
i. Chagas Disease
j. Babesiosis
3. Pathogen Reduction
4. Leukocyte Reduction
- Background
- Methods
B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers Manufactured by:
- Abbott
- Beckman Coulter/Danaher
- Bio-Rad
- BioMerieux
- Gen-Probe
- Grifols
- Immucor
- Nanosphere
- Ortho-Clinical Diagnostics
- Roche
- Sarstedt
- Siemens
- Tecan
C. Major in VitrDiagnostic Technologies and Their Potential Applications
1. Molecular Diagnostics
a. Overview
b. NAT
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
a. Technological Principle
b. Chemiluminescence
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- EMIT
- Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
4. Microtitration Plates
5. IT and Automation
6. Lasers
7. Robotics
8. Synthetic Red Cell Substitutes
9. Genetically Engineered Blood Components
a. Albumin
b. Factor VIII
c. Alpha-2 Antiplasmin
d. Antithrombin III
e. Factor IX
f. Von Willebrand's Factor
g. Fibrinogen
h. t-PA
10. Blood Preservation
11. Autologous Blood Transfusion/Freezing

VI. France
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers' Sales and Market Shares

VII. Competitive Assessments
- Abbott
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- BioMerieux
- Bio-Rad
- Diagast
- DiaSorin
- Fujirebio/Innogenetics
- Hologic/Gen-Probe
- Grifols
- Immucor
- Novartis Diagnostics
- Ortho-Clinical Diagnostics
- Orchid CellMark
- Proteome Sciences
- Quest Diagnostics
- Quidel
- Roche
- Siemens
- Tecan

VIII. Appendix: Assumed Currency Exchange Rates

List of Tables

Major Companies Developing or Marketing Blood Typing and Grouping Tests
Major Companies Developing or Marketing HLA Typing Tests
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Blood Bank Analyzers

Executive Summary Table: France, Total Blood Bank Test Volume and Reagent Sales Forecast By Test Category
France, Facilities Performing Blood Bank Tests by Market Segment
France, Hospital Laboratories Performing Blood Bank Tests by Bed Size
France, Commercial/Private Laboratories Performing Blood Bank Tests by Annual Test Volume
France, All Market Segments Blood Typing and Grouping Test Volume Forecast by Market Segment
France, All Market Segments Blood Typing and Grouping Test Volume Forecast
France, Hospital Laboratories Blood Typing and Grouping Test Volume Forecast
France, Blood Banks Blood Typing and Grouping Test Volume Forecast
France, Commercial/Private Laboratories Blood Typing and Grouping Test Volume Forecast
France, All Market Segments Infectious Disease Screening Test Volume Forecast by Market Segment
France, All Market Segments Infectious Disease Screening Test Volume Forecast
France, Blood Banks Infectious Disease Screening Test Volume Forecast
France, Commercial/Private Laboratories Infectious Disease Screening Test Volume Forecast
France, Hospital Laboratories Infectious Disease Screening Test Volume Forecast
France, All Market Segments Blood Typing and Grouping Reagent Market Forecast by Market Segment
France, All Market Segments Blood Typing and Grouping Reagent Market Forecast By Major Test
France, Hospital Laboratories Blood Typing and Grouping Reagent Market Forecast By Major
France, Blood Banks Blood Typing and Grouping Reagent Market Forecast By Major Test
France, Commercial/Private Laboratories Blood Typing and Grouping Reagent Market Forecast By Major Test
France, All Market Segments Infectious Disease Screening Reagent Market Forecast by Market Segment
France, All Market Segments Infectious Disease Screening Reagent Market Forecast By Test
France, Blood Banks Infectious Disease Screening Reagent Market Forecast by Test
France, Commercial/Private Laboratories Infectious Disease Screening Reagent Market Forecast By Test
France, Hospital Laboratories Infectious Disease Screening Reagent Market Forecast by Test
France, Major Suppliers of Blood Typing and Grouping Reagents Estimated Sales and Market Shares
France, HIV/HTLV Blood Screening Market, Reagent Sales by Major Supplier
France, Hepatitis Blood Screening Market, Reagent Sales by Major Supplier
France, HIV/Hepatitis NAT Screening Market Reagent Sales by Major Supplier
France, CMV Blood Screening Market, Reagent Sales By Major Supplier
France, Syphilis Blood Screening Market, Reagent Sales By Major Supplier